Literature DB >> 20645534

Annular leukocytoclastic vasculitis associated with sorafenib administration.

David J Najarian1, Vathani Packianathan, Nathalie C Zeitouni.   

Abstract

Only one case of vasculitis associated with sorafenib has been reported, and the authors now present the first reported case of annular leukocytoclastic vasculitis (LCV) linked to sorafenib administration.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20645534

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN： 1545-9616            Impact factor:   2.114


  3 in total

1.  Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors.

Authors:  Emmanuelle Faye; Emmanuelle Bondon-Guitton; Pascale Olivier-Abbal; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2013-06-09       Impact factor: 2.953

2.  Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience.

Authors:  Ah Ran Cho; Young Hee Yoon; June Gone Kim; Yoon Jeon Kim; Joo Yong Lee
Journal:  J Korean Med Sci       Date:  2018-02-12       Impact factor: 2.153

3.  Annular leukocytoclastic vasculitis associated with anti-tuberculosis medications: a case report.

Authors:  Kumutnart Chanprapaph; Wanjarus Roongpisuthipong; Kunlawat Thadanipon
Journal:  J Med Case Rep       Date:  2013-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.